Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Certain gene variations are not a major cause of male infertility in Nigerian men.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Exposure to particulate matter worsens postpartum hair loss by affecting inflammation and cell death pathways.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

FGF21 can help reduce skin inflammation caused by C. acnes.